These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10463648)

  • 1. Correlation between enhancing lesion number and volume on standard and triple dose gadolinium-enhanced brain MRI scans from patients with multiple sclerosis.
    Rovaris M; Bastianello S; Capra R; Comi G; Yousry TA; Filippi M
    Magn Reson Imaging; 1999 Sep; 17(7):985-8. PubMed ID: 10463648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.
    Rovaris M; Mastronardo G; Prandini F; Bastianello S; Comi G; Filippi M
    J Neurol Sci; 1999 Apr; 164(2):148-52. PubMed ID: 10402026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI evolution of new MS lesions enhancing after different doses of gadolinium.
    Rovaris M; Mastronardo G; Gasperini C; Prandini F; Yousry TA; Filippi M
    Acta Neurol Scand; 1998 Aug; 98(2):90-3. PubMed ID: 9724005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between MRI and short-term clinical activity in multiple sclerosis: comparison between standard- and triple-dose Gd-enhanced MRI.
    Rovaris M; Rodegher M; Comi G; Filippi M
    Eur Neurol; 1999; 41(3):123-7. PubMed ID: 10202242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis.
    Filippi M; Rovaris M; Gasperini C; Capra R; Bastianello S; Kuhne I; Yousry TA
    J Neuroimaging; 1998 Apr; 8(2):88-93. PubMed ID: 9557146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium.
    Filippi M; Rocca MA; Rizzo G; Horsfield MA; Rovaris M; Minicucci L; Colombo B; Comi G
    Neurology; 1998 May; 50(5):1289-93. PubMed ID: 9595976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients.
    Rovaris M; Capra R; Martinelli V; Gasperini C; Prandini F; Pozzilli C; Comi G; Filippi M
    J Neurol Sci; 1999 Dec; 171(2):130-4. PubMed ID: 10581379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis.
    Gasperini C; Paolillo A; Rovaris M; Yousry TA; Capra R; Bastianello S; Filippi M
    Magn Reson Imaging; 2000 Jul; 18(6):761-3. PubMed ID: 10930786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology.
    Filippi M; Rovaris M; Capra R; Gasperini C; Prandini F; Martinelli V; Horsfield MA; Bastianello S; Sormani MP; Pozzilli C; Comi G
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):386-9. PubMed ID: 10449565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis.
    Filippi M; Barkhof F; Bressi S; Yousry TA; Miller DH
    Mult Scler; 1997 Aug; 3(4):226-30. PubMed ID: 9372504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images.
    Rovaris M; Barkhof F; Bastianello S; Gasperini C; Tubridy N; Yousry TA; Sormani MP; Viti B; Miller DH; Filippi M
    J Neurol; 1999 Oct; 246(10):920-5. PubMed ID: 10552239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoteridol in multiple sclerosis patients. A comparison of single and triple dose with immediate vs. delayed imaging.
    Wolansky LJ; Finden SG; Chang R; Conigliari M; Lee HJ; Shaderowsky PD; Cook SD
    Clin Imaging; 1998; 22(6):385-92. PubMed ID: 9876905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
    Filippi M; Yousry T; Campi A; Kandziora C; Colombo B; Voltz R; Martinelli V; Spuler S; Bressi S; Scotti G; Comi G
    Neurology; 1996 Feb; 46(2):379-84. PubMed ID: 8614498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis.
    Filippi M; Mastronardo G; Bastianello S; Rocca MA; Rovaris M; Gasperini C; Pozzilli C; Comi G
    J Neurol Sci; 1998 Jul; 159(1):94-101. PubMed ID: 9700710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: correlations with changes of T2 and magnetization transfer lesion loads.
    Filippi M; Rocca MA; Horsfield MA; Comi G
    J Neurol Sci; 1998 Jun; 158(2):203-8. PubMed ID: 9702692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three subsequent single doses of gadolinium chelate for brain MR imaging in multiple sclerosis.
    Sardanelli F; Iozzelli A; Losacco C; Murialdo A; Filippi M
    AJNR Am J Neuroradiol; 2003 Apr; 24(4):658-62. PubMed ID: 12695199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.
    Kappos L; Moeri D; Radue EW; Schoetzau A; Schweikert K; Barkhof F; Miller D; Guttmann CR; Weiner HL; Gasperini C; Filippi M
    Lancet; 1999 Mar; 353(9157):964-9. PubMed ID: 10459905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
    Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
    Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
    Filippi M; Rovaris M; Capra R; Gasperini C; Yousry TA; Sormani MP; Prandini F; Horsfield MA; Martinelli V; Bastianello S; Kühne I; Pozzilli C; Comi G
    Brain; 1998 Oct; 121 ( Pt 10)():2011-20. PubMed ID: 9798753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.